Search results

Filter

Filetype

Your search for "*" yielded 125670 hits

MultiPark grows – new research groups

This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studies in animal models. Jacob Vogel’s team uses AI to analyze clinical data for improved understanding as well as patient-tailored diagnosis and care of neurodegenerative disease patients. Say hello to Åsa Mackenzie and Jac

https://www.multipark.lu.se/article/multipark-grows-new-research-groups - 2026-05-09

From molecule to patient – Six promising projects to advance Parkinson's research

What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease? And how should patients in very advanced disease stages be treated to maintain their quality of life? These questions may soon have answers thanks to several ong

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research - 2026-05-09

A new reliable blood marker reveals the extent of Alzheimer’s pathology in the brain

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer’s drugs. In brief:A newly discovered blood marker, MTBR-tau243, can reveal how much Alzheimer’s disease pathology is present in the brain. The hi

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2026-05-09

More opportunities to test for Alzheimer’s using new analytical method

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the healthcare system globally,” say the researchers behind the study. In brief:The blood-based marker (P-tau217) may start to change several years before the onset of Al

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2026-05-09

HD webinar on 22 November 2023

Curious about HD research and wish to learn more? The European Huntington Association/Moving Forward Team is inviting you to a webinar in Norwegian on 22 November. Astri Arnesen, the President of the European Huntington Association, will speak about international HD research, Lasse Pihlstrøm, a Norwegian HD neurologist and researcher, will address HD studies and trials in Norway, and Åsa Petersén,

https://www.huntington-research.lu.se/article/hd-webinar-22-november-2023 - 2026-05-09

Petersen gives a research update at the National meeting for HD in Sweden!

The National meeting for HD is a yearly event arranged by the patients’ organization RHS. This year, 2023, it took place in Gothenburg on 30 November. All talks at the meeting are available on RHS website; only in Swedish.You find Åsa Petersén’s research update about 13 minutes into the film. To access the video, go to RHS website:RHS website

https://www.huntington-research.lu.se/article/petersen-gives-research-update-national-meeting-hd-sweden - 2026-05-09

Welcome to info night on HD on 22 April 2024!

Every spring, Huntington Disease Center in Lund traditionally hosts an information night on Huntington disease. This year is no exception! The program is set for the evening:Staff from the clinical team and representatives from the patients’ organization, RHS, as well as HD researchers, will give talks about different aspects of the the disease and the current research. And, as always, there will

https://www.huntington-research.lu.se/article/welcome-info-night-hd-22-april-2024 - 2026-05-09

Bergh presented at the NMT Days

Sofia Bergh, PhD student in TNU, gave two presentations on Huntington disease on 11 and 12 March 2024 during the NMT Days.This is an annual event, arranged by the Faculty of Science, the Faculty of Medicine and the Faculty of Engineering at Lund University. A week of talks and demonstrations on a variety of topics show today’s research, and students in upper secondary school and their teachers are

https://www.huntington-research.lu.se/article/bergh-presented-nmt-days - 2026-05-09

Congratulations, Sofia Bergh!

Sofia passed her half time review on 28 May 2024. Sofia Bergh presented her work titled "Cellular and molecular mechanisms of hypothalamic pathology in Huntington disease and the amyotrophic lateral sclerosis/frontotemporal dementia disease spectrum" before the audience and the reviewers Niels Henning Skotte, research group leader, Department for Drug Design and Pharmacology, Molecular Neuroprotec

https://www.huntington-research.lu.se/article/congratulations-sofia-bergh - 2026-05-09

Webinar "Research Updates for the Nordic Countries".

For the second time, the European Huntington Association/Moving Forward initiative for the Nordic countries will be hosting a webinar on research updates. The Webinar will be held on 11th June, from 18:00 CET to 19:15 CET. You need to register beforehand to be able to join.Registration link: https://us02web.zoom.us/meeting/register/tZEkdeyupz4oH9KRCnkguo_KMuS0Y6…Åsa Petersén will be talking about

https://www.huntington-research.lu.se/article/webinar-research-updates-nordic-countries - 2026-05-09

Congratulations, Oskar!

Oskar Simonsson har completed his Master's studies and passed with Distinction. Oskar has been with TNU since the end of October 2023 to work on his Master's thesis. In the end of May he presented his work "Effects of TDP-43 overexpression in oxytocin neurons on neuropathology and metabolism in mice". Congratulations to your Master of Science in Biomedicine, Oskar!

https://www.huntington-research.lu.se/article/congratulations-oskar - 2026-05-09

JPND project kickoff in Istanbul

Together with researchers from Germany, Canada, Turkey and the Czech Republic Åsa Petersén was awarded the JPND grant for the project Delineating the role of HTT Cis-Variants in the pathogenesis of Huntington disease. In Sweden the grant  is funded by Vetenskapsrådet, the Swedish Research Council, and Petersén was awarded SEK 2 500 000.To initiate the project, a kickoff meeting was held in Istanbu

https://www.huntington-research.lu.se/article/jpnd-project-kickoff-istanbul - 2026-05-09

RHS National meeting 2024

Åsa Petersén will participate in the HD patients' organization's national meeting later in September. The patients’ organization, RHS, is inviting you to the national meeting in Gothenburg on 26 September 2024. Åsa Petersén will give an overview of the current HD research and the day will include information on guidelines for physiotherapy, and much more. The meeting will be held in Swedish.Sign u

https://www.huntington-research.lu.se/article/rhs-national-meeting-2024 - 2026-05-09

Welcome to Petersén’s talk on psychiatric health in HD

Åsa Petersén is one of the lecturers at MultiPark Café in October. On Wednesday 16 October, at 17.00-19.00, MultiPark Café is hosting an evening with lectures on “Psychiatric health in neurodegenerative diseases”. Åsa Petersén will talk about “Psychiatric health in Huntington’s disease”.All talks are in Swedish.Link to the event on MultiPark’s website

https://www.huntington-research.lu.se/article/welcome-petersens-talk-psychiatric-health-hd - 2026-05-09

Petersén will give a talk on HD for young adults

The Swedish patients' organization RHS is arranging a weekend on Huntingon disease for young adults on 18-20 October 2024 in Karlstad. During the weekend there will be presentations on various topics, like genetic counselling, and the weekend also offers an opportunity to network with other young adults and to share experiences.Åsa Petersén will give a talk on HD research and present the latest up

https://www.huntington-research.lu.se/article/petersen-will-give-talk-hd-young-adults - 2026-05-09